Trove
Sign In Get Started

HOUSE_OVERSIGHT_024102.jpg

1.75 MB
View Original

Extraction Summary

0
People
43
Organizations
0
Locations
0
Events
1
Relationships
2
Quotes

Document Information

Type: Financial record (investment portfolio summary)
File Size: 1.75 MB
Summary

This document is a confidential financial schedule for 'Sprout Capital IX, L.P. (Healthcare Technology Portfolio)' as of March 31, 2014. It details realized and unrealized investments in numerous healthcare and biotechnology companies, listing vintage years, costs, realized values, and IRRs. The document bears a 'HOUSE_OVERSIGHT' footer, indicating it was part of a congressional investigation.

Organizations (43)

Name Type Context
Sprout Capital IX, L.P.
House Oversight Committee
Adolor Corporation
Affymax, Inc.
Aspire Medical
Aspreva Pharmaceuticals
Aureon Biosciences, Inc.
Auxilium Pharmaceuticals, Inc.
Corixa Corporation
eHealth, Inc.
Epicor Medical, Inc.
ePocrates, Inc.
Focus Technologies, Inc.
Gryphon Therapeutics
Ilypsa, Inc.
ISTA Pharmaceuticals, Inc.
Kalypsys
Lathian Systems, Inc
Metabasis Therapeutics, Inc.
NeuroVista Corp.
NxStage Medical, Inc.
Nyco Holdings ApS
Pharsight Corporation
Phylos, Inc.
Progen PharmaInc.
Cellgate
Protedyne Corporation
Radiant Medical, Inc.
Sirna Therapeutics, Inc.
Spiration, Inc.
Tolerx, Inc.
Triple Point
VascA, Inc.
Visiogen, Inc.
VNUS Medical Technologies, Inc.
Expression Diagnostics
XDx
Intrinsic Therapeutics, Inc.
Labcyte, Inc.
Picoliter
Relypsa, Inc.
Sopherion Therapeutics, Inc.
Spinewave

Relationships (1)

Sprout Capital IX, L.P. → Investor/Investee → Various Healthcare Companies
Table listing investments held by Sprout Capital IX, L.P. in various healthcare companies.

Key Quotes (2)

"Please refer to Endnotes I,J,K,L,M and N in this Appendix."
Source
HOUSE_OVERSIGHT_024102.jpg
Quote #1
"CONTROL NUMBER 257 - CONFIDENTIAL"
Source
HOUSE_OVERSIGHT_024102.jpg
Quote #2

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein document